Urologix, Inc. (ULGX)
ULGX Stock Price Chart
Explore Urologix, Inc. interactive price chart. Choose custom timeframes to analyze ULGX price movements and trends.
ULGX Company Profile
Discover essential business fundamentals and corporate details for Urologix, Inc. (ULGX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 May 1996
Employees
61.00
Website
https://www.urologix.comCEO
Bryon Merade
Description
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
ULGX Financial Timeline
Browse a chronological timeline of Urologix, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
ULGX Stock Performance
Access detailed ULGX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.